569 related articles for article (PubMed ID: 27888187)
1. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
3. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
Daghlas I; Lever TE; Leary E
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
[TBL] [Abstract][Full Text] [Related]
4. Dysphagia in Amyotrophic Lateral Sclerosis: Relationships between disease progression and Fiberoptic Endoscopic Evaluation of Swallowing.
Fattori B; Siciliano G; Mancini V; Bastiani L; Bongioanni P; Caldarazzo Ienco E; Barillari MR; Romeo SO; Nacci A
Auris Nasus Larynx; 2017 Jun; 44(3):306-312. PubMed ID: 27569290
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort.
Thakore NJ; Lapin BR; Pioro EP;
Muscle Nerve; 2018 Jun; 57(6):937-945. PubMed ID: 29244213
[TBL] [Abstract][Full Text] [Related]
6. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.
Franchignoni F; Mora G; Giordano A; Volanti P; Chiò A
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1340-5. PubMed ID: 23516308
[TBL] [Abstract][Full Text] [Related]
7. Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients.
Pinto S; Gromicho M; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):445-448. PubMed ID: 31032642
[No Abstract] [Full Text] [Related]
8. Health Status Perspectives in Amyotrophic Lateral Sclerosis.
Pinto S; de Carvalho M
Neurodegener Dis; 2017; 17(6):323-329. PubMed ID: 29084402
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model.
Bakker LA; Schröder CD; van Es MA; Westers P; Visser-Meily JMA; van den Berg LH
J Neurol; 2017 Jul; 264(7):1413-1420. PubMed ID: 28608303
[TBL] [Abstract][Full Text] [Related]
10. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
Cheong I; Deelchand DK; Eberly LE; Marjańska M; Manousakis G; Guliani G; Walk D; Öz G
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):294-301. PubMed ID: 30467209
[TBL] [Abstract][Full Text] [Related]
12. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
[TBL] [Abstract][Full Text] [Related]
14. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
15. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
16. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis?
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):120-3. PubMed ID: 25205208
[TBL] [Abstract][Full Text] [Related]
17. A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements.
Franchignoni F; Mandrioli J; Giordano A; Ferro S;
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):331-7. PubMed ID: 25916346
[TBL] [Abstract][Full Text] [Related]
18. Diaphragmatic CMAP amplitude from phrenic nerve stimulation predicts functional decline in ALS.
Miranda B; Gromicho M; Pereira M; Pinto S; Swash M; de Carvalho M
J Neurol; 2020 Jul; 267(7):2123-2129. PubMed ID: 32253508
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
[TBL] [Abstract][Full Text] [Related]
20. Cortical Thinning Pattern of Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis: a Surface-based Morphometry Study.
Chen ZY; Liu MQ; Ma L
Chin Med Sci J; 2018 Jun; 33(2):100-106. PubMed ID: 29976279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
